Cardiovascular risk and therapeutic intervention for the early morning surge in blood pressure and heart rate.
about
Evening versus morning dosing regimen drug therapy for hypertensionAngiotensin II receptor blockers and cardiovascular outcomes: what does the future hold?Endothelial function, blood pressure control, and risk modification: impact of irbesartan alone or in combination.Effects of verapamil SR and atenolol on 24-hour blood pressure and heart rate in hypertension patients with coronary artery disease: an international verapamil SR-trandolapril ambulatory monitoring substudyCurrent status of angiotensin receptor blockers for the treatment of cardiovascular diseases: focus on telmisartan.Maximising antihypertensive effects of angiotensin II receptor blockers with thiazide diuretic combination therapy: focus on irbesartan/hydrochlorothiazideThe morning blood pressure surge: therapeutic implications.The importance of sleep blood pressure.Nocturnal blood pressure, morning blood pressure surge, and cerebrovascular events.Is it possible to manage hypertension and evaluate therapy without ambulatory blood pressure monitoring?Olmesartan medoxomil-based antihypertensive therapy evaluated by ambulatory blood pressure monitoring: efficacy in high-risk patient subgroups.Managing hypertension with ambulatory blood pressure monitoring.Endocrine and cardiovascular rhythms differentially adapt to chronic phase-delay shifts in rats.Effect of the angiotensin II type 1 receptor antagonist olmesartan on cerebral hemodynamics and rehabilitation outcomes in hypertensive post-stroke patients.Pre-awakening diastolic hypotension in treated hypertensive patients: prevalence and predictors.Blood pressure-lowering effect and duration of action of bedtime administration of doxazosin determined by home blood pressure measurement.The angiotensin II type 1 receptor antagonist olmesartan preserves cerebral blood flow and cerebrovascular reserve capacity, and accelerates rehabilitative outcomes in hypertensive patients with a history of stroke.Static magnetic field blood pressure buffering, baroreflex vs. vascular blood pressure control mechanism.ABPM comparison of the anti-hypertensive profiles of telmisartan and enalapril in patients with mild-to-moderate essential hypertension.Time-effect profile of antihypertensive agents assessed with trough/peak ratio, smoothness index and dose omission: an ambulatory blood pressure monitoring study with trandolapril vs. quinapril.An open-label study investigating the efficacy and safety of 12-96 weeks of telmisartan treatment in patients with hypertension.Differential time effect profiles of amlodipine, as compared to valsartan, revealed by ambulatory blood pressure monitoring, self blood pressure measurements and dose omission protocol.Preparation and evaluation of a novel delayed-onset sustained-release system of propranolol hydrochloride.Changes in respiratory disorder parameters during the night in patients with obstructive sleep apnoea.A comparison of morning blood pressure surge in African Americans and whites.
P2860
Q24236288-4B00333C-7E16-4F02-95AE-69D873AB9EA4Q35154540-FAAC5B2E-8730-4044-8C7A-BCB4C476332AQ35210505-18CFE57F-D5D3-448A-A9FF-7E52887C2AFBQ35249346-C0BC3964-D092-4C21-A473-7518D3A5C271Q36014340-CEE34CE3-488C-4402-97FC-08D1A8F922E9Q36432174-2A9148D3-0A46-487C-B6D0-71D51D66E516Q37079675-9502CE43-1B40-4B6A-B8C7-ED77AF259FC7Q37763198-232D74BC-2581-4005-BC11-F2E070831DFFQ38005055-2F8762C2-8C8A-475B-BE40-F3C3C330B362Q38013690-1534E789-0CAB-4D3A-934C-1B5F9A71BD2BQ38056968-6B974953-C10E-4403-A779-3CC427E776C0Q38331093-2794925A-4339-4E1A-8BC4-DDFD6BDA6824Q39559322-038DCE48-2B99-404E-92BE-F853D32A2674Q39932185-542D2E26-10F4-4FC6-8571-E75FA941022DQ41556886-A9560C1D-3EAC-4B67-9078-686E1964EBCBQ42956384-62B83061-0C1E-4746-A314-59FE0DEC556AQ43093957-9426234F-42EF-4409-857D-F87CD56B32E5Q43165549-BF6040A4-C128-4E36-BB28-7B1446242057Q44277073-9754B731-80AF-4FE1-879C-B4C8D5890605Q44396923-269E8B98-EBE2-4B8A-962A-67DD80B60928Q44715970-C38B1A32-0369-46C8-9F38-EA26907E39ACQ45018848-C48D7AE6-3EDB-4F31-8FCB-01C862B7EDF8Q46543675-0880ED94-86DF-40F8-AA57-C1FAC8555BBEQ48336902-AC0FB421-4079-4FFD-8818-A4EB2D1722A9Q48554236-5AFDEFC6-3C15-4B3A-96D7-C9BE730AA5E1
P2860
Cardiovascular risk and therapeutic intervention for the early morning surge in blood pressure and heart rate.
description
2001 nî lūn-bûn
@nan
2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Cardiovascular risk and therap ...... blood pressure and heart rate.
@ast
Cardiovascular risk and therap ...... blood pressure and heart rate.
@en
Cardiovascular risk and therap ...... blood pressure and heart rate.
@nl
type
label
Cardiovascular risk and therap ...... blood pressure and heart rate.
@ast
Cardiovascular risk and therap ...... blood pressure and heart rate.
@en
Cardiovascular risk and therap ...... blood pressure and heart rate.
@nl
prefLabel
Cardiovascular risk and therap ...... blood pressure and heart rate.
@ast
Cardiovascular risk and therap ...... blood pressure and heart rate.
@en
Cardiovascular risk and therap ...... blood pressure and heart rate.
@nl
P1476
Cardiovascular risk and therap ...... blood pressure and heart rate.
@en
P2093
P356
10.1097/00126097-200104000-00001
P577
2001-04-01T00:00:00Z